Legend Biotech (LEGN) Net Cash Flow (2019 - 2025)
Legend Biotech (LEGN) posted Net Cash Flow of $625.7 million for Q4 2025, up 6507.18% on a QoQ basis from $9.5 million in Q3 2025, and up 467.41% year-over-year from $110.3 million in Q4 2024.
Legend Biotech (LEGN) has 7 years of Net Cash Flow data on file, last reported at $625.7 million in Q4 2025.
- In Q4 2025, Net Cash Flow rose 467.41% year-over-year to $625.7 million; the TTM figure through Dec 2025 stood at $609.2 million (up 161.6% YoY), while the FY2025 annual figure was $609.1 million, up 161.59% from the prior year.
- Net Cash Flow climbed to $625.7 million in Q4 2025, from $9.5 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $625.7 million in Q4 2025 and bottomed at -$696.3 million in Q2 2024.
- A 5-year average of -$4.0 million and a median of -$56.8 million in 2021 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2022 — Net Cash Flow slumped 611.55% — and 2023, when it soared 19899.89%.
- Year by year, Net Cash Flow stood at -$69.9 million in 2021, then slumped by 84.4% to -$128.9 million in 2022, then soared by 342.72% to $312.8 million in 2023, then plunged by 154.45% to -$170.3 million in 2024, then surged by 467.41% to $625.7 million in 2025.
- The last three Net Cash Flow figures came in at $625.7 million (Q4 2025), $9.5 million (Q3 2025), and -$179.6 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 625.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 457.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -152.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 60.68 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 57.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 625.70 Mn |
| Dec 31, 2025 | 625.70 Mn |
| Sep 30, 2025 | 9.47 Mn |
| Sep 30, 2025 | 9.47 Mn |
| Jun 30, 2025 | -179.56 Mn |
| Jun 30, 2025 | -179.56 Mn |
| Mar 31, 2025 | 153.55 Mn |
| Mar 31, 2025 | 153.55 Mn |
| Dec 31, 2024 | -170.30 Mn |
| Dec 31, 2024 | -170.30 Mn |
| Sep 30, 2024 | 257.50 Mn |
| Sep 30, 2024 | 257.50 Mn |
| Jun 30, 2024 | -696.33 Mn |
| Jun 30, 2024 | -696.33 Mn |
| Mar 31, 2024 | -379.80 Mn |
| Mar 31, 2024 | -379.80 Mn |
| Dec 31, 2023 | 312.79 Mn |
| Dec 31, 2023 | 312.79 Mn |
| Sep 30, 2023 | -268.96 Mn |
| Sep 30, 2023 | -268.96 Mn |
| Jun 30, 2023 | 570.80 Mn |
| Jun 30, 2023 | 570.80 Mn |
| Mar 31, 2023 | -123.63 Mn |
| Mar 31, 2023 | -123.63 Mn |
| Dec 31, 2022 | -128.87 Mn |
| Dec 31, 2022 | -128.87 Mn |
| Sep 30, 2022 | 433.50 Mn |
| Sep 30, 2022 | 433.50 Mn |
| Jun 30, 2022 | 2.85 Mn |
| Jun 30, 2022 | 2.85 Mn |
| Mar 31, 2022 | -311.16 Mn |
| Mar 31, 2022 | -311.16 Mn |
| Dec 31, 2021 | -69.89 Mn |
| Dec 31, 2021 | -69.89 Mn |
| Sep 30, 2021 | -149.12 Mn |
| Sep 30, 2021 | -149.12 Mn |
| Jun 30, 2021 | 75.47 Mn |
| Jun 30, 2021 | 75.47 Mn |
| Mar 31, 2021 | -43.73 Mn |
| Mar 31, 2021 | -43.73 Mn |
| Dec 31, 2020 | -246.51 Mn |
| Dec 31, 2020 | -246.51 Mn |
| Sep 30, 2020 | -113.34 Mn |
| Sep 30, 2020 | -113.34 Mn |
| Jun 30, 2020 | 393.71 Mn |
| Jun 30, 2020 | 393.71 Mn |
| Mar 31, 2020 | 85.46 Mn |
| Mar 31, 2020 | 85.46 Mn |
| Dec 31, 2019 | 46.78 Mn |
| Dec 31, 2019 | 46.78 Mn |
| Sep 30, 2019 | -1.40 Mn |
| Sep 30, 2019 | -1.40 Mn |
| Jun 30, 2019 | -81.97 Mn |
| Jun 30, 2019 | -81.97 Mn |